(Total Views: 389)
Posted On: 03/20/2020 10:31:50 AM
Post# of 155704
Look at BLPH recent history. Yesterday $3.39 and now around $17.50
September of 2018 it traded at this amount $18
July of 2018 it was around $40
5 years ago $166
Those shareholders have been long suffering
The advantage they got was expanded access - they can use their drug - meaning real sales and revenue.
We don’t seem to yet have an approved trial protocol and seem to need to wait until next week for that approval and then we need to conduct 75 person study.
Maybe our emergency IMD will get us expanded access
Would sure be nice to have a submitted CMC section since we only needed 3 month stability which was reached in December.
Still don’t understand reason for delay in getting data from our contract manufacturing “partner”.
Approved Mfg would be nice to have if we gat an emergency approved use and it it hard to approved Mfg if it gets submitted more than 3 months after data should have been available.
IMO
September of 2018 it traded at this amount $18
July of 2018 it was around $40
5 years ago $166
Those shareholders have been long suffering
The advantage they got was expanded access - they can use their drug - meaning real sales and revenue.
We don’t seem to yet have an approved trial protocol and seem to need to wait until next week for that approval and then we need to conduct 75 person study.
Maybe our emergency IMD will get us expanded access
Would sure be nice to have a submitted CMC section since we only needed 3 month stability which was reached in December.
Still don’t understand reason for delay in getting data from our contract manufacturing “partner”.
Approved Mfg would be nice to have if we gat an emergency approved use and it it hard to approved Mfg if it gets submitted more than 3 months after data should have been available.
IMO
(0)
(0)
